LAVA Therapeutics BV (LVTX)

LAVA Therapeutics N.V. is a biotechnology company developing a portfolio of bispecific gamma-delta T cell engagers (gamma-delta bsTCEs) for the treatment of solid tumors and hematologic malignancies based on its proprietary platform. The company’s innovative approach leverages bispecific antibodies to activate Vγ9Vδ2 T cells upon binding to membrane-expressed tumor associated antigens. Activated Vγ9Vδ2 T cells are engaged for direct, selective tumor cell killing. The company’s lead program, LAVA-051, is expected to enter a Phase 1/2a clinical study in hematologic malignancies in the first half of 2021. The company has established a highly experienced research and development team located in Utrecht, the Netherlands and Philadelphia, USA.

Data as of 2021-08-02 09:28:16 -0400
Market Cap140.198 Million Shares Outstanding25.352 Million Avg 30-day Volume35.652 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.14 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low17.2 / 5.52 Next Earnings Date2021-08-23 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) No data
Funds Holding: 24 0 15 (0.88%) No data
13F shares: 9.206 Million 0 5.118 Million No data
% Ownership No data
New Positions: 23 15 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls No data
Total Puts No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding LVTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LVTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LAVA THERAPEUTICS NV LVTX 2021-08-05 17:45:03 UTC -5.6656 5.7456 500
LAVA THERAPEUTICS NV LVTX 2021-08-05 17:15:03 UTC -5.6656 5.7456 1000
LAVA THERAPEUTICS NV LVTX 2021-08-05 16:45:02 UTC -5.6656 5.7456 1000
LAVA THERAPEUTICS NV LVTX 2021-08-05 16:15:03 UTC -5.6656 5.7456 1000
LAVA THERAPEUTICS NV LVTX 2021-08-05 15:45:03 UTC -5.6656 5.7456 1000
LAVA THERAPEUTICS NV LVTX 2021-08-05 15:15:02 UTC -5.6656 5.7456 1000
LAVA THERAPEUTICS NV LVTX 2021-08-05 14:45:02 UTC -5.145 5.225 1000
LAVA THERAPEUTICS NV LVTX 2021-08-05 13:15:03 UTC -5.145 5.225 10000
LAVA THERAPEUTICS NV LVTX 2021-08-05 12:45:03 UTC -5.145 5.225 10000
LAVA THERAPEUTICS NV LVTX 2021-08-04 22:15:03 UTC -5.145 5.225 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 21:45:04 UTC -5.0841 5.1641 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 21:15:03 UTC -5.0841 5.1641 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 20:45:03 UTC -5.0619 5.1419 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 20:15:04 UTC -5.0619 5.1419 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 19:45:03 UTC -5.0619 5.1419 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 19:15:03 UTC -5.0619 5.1419 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 18:45:04 UTC -4.8206 4.9006 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 18:15:03 UTC -4.8206 4.9006 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 17:45:03 UTC -4.8967 4.9767 30000
LAVA THERAPEUTICS NV LVTX 2021-08-04 17:15:03 UTC -4.8967 4.9767 30000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Balanced Risk Fund LVTX -97.0 shares, $-1154.3 2021-04-30 N-PORT

Elevate your investments